Recurrent rhabdomyolysis secondary to hyponatremia in a patient with primary psychogenic polydipsia. 2015

Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
Serviço de Medicina Interna, Hospital Geral, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

Rhabdomyolysis is characterized by the destruction of skeletal muscle tissue, and its main causes are trauma, toxic substances and electrolyte disturbances. Among the latter is hyponatremia-induced rhabdomyolysis, a rare condition that occurs mainly in patients with psychogenic polydipsia. Psycogenic polydipsia mostly affects patients with schizophrenia, coursing with hyponatremia in almost 25% of the cases. It is also in this context that rhabdomyolysis secondary to hyponatremia occurs most often. In this article, the case of a 49-year-old male with a history of schizophrenia, medicated with clozapine, and brought to the emergency room in a state of coma and seizures is described. Severe hypoosmolar hyponatremia with cerebral edema was found on a computed tomography examination, and a subsequent diagnosis of hyponatremia secondary to psychogenic polydipsia was made. Hyponatremia correction therapy was started, and the patient was admitted to the intensive care unit. After the hyponatremia correction, the patient presented with analytical worsening, showing marked rhabdomyolysis with a creatine phosphokinase level of 44.058 UI/L on day 3 of hospitalization. The condition showed a subsequent progressive improvement with therapy, with no occurrence of kidney damage. This case stresses the need for monitoring rhabdomyolysis markers in severe hyponatremia, illustrating the condition of rhabdomyolysis secondary to hyponatremia induced by psychogenic polydipsia, which should be considered in patients undergoing treatment with neuroleptics.

UI MeSH Term Description Entries
D007010 Hyponatremia Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed) Hyponatremias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012206 Rhabdomyolysis Necrosis or disintegration of skeletal muscle often followed by myoglobinuria. Rhabdomyolyses
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D059607 Polydipsia, Psychogenic A clinical disorder characterized by excessive fluid intake (polydipsia); HYPONATREMIA; and POLYURIA in SCHIZOPHRENIA and other psychiatric disorders. Impaired water metabolism in psychogenic polydipsia can result in WATER INTOXICATION. Polydipsia, Primary,Polydipsias, Primary,Polydipsias, Psychogenic,Primary Polydipsia,Primary Polydipsias,Psychogenic Polydipsia,Psychogenic Polydipsias

Related Publications

Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
October 2001, Medicina clinica,
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
May 1995, Mayo Clinic proceedings,
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
January 2023, Acta endocrinologica (Bucharest, Romania : 2005),
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
January 2012, The American journal of case reports,
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
April 1986, Annales medico-psychologiques,
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
April 2015, Pediatric emergency care,
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
December 1980, Archives of internal medicine,
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
December 2006, Progress in neuro-psychopharmacology & biological psychiatry,
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
September 1998, The Annals of pharmacotherapy,
Diana Tavares Aguiar, and Catarina Monteiro, and Paula Coutinho
September 1984, New York state journal of medicine,
Copied contents to your clipboard!